OTCMKTS:RDSMY

Koninklijke DSM Stock Forecast, Price & News

$45.62
0.00 (0.00 %)
(As of 04/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$45.28
Now: $45.62
$46.17
50-Day Range
$41.61
MA: $43.34
$45.62
52-Week Range
$29.31
Now: $45.62
$46.17
Volume21,590 shs
Average Volume35,074 shs
Market Capitalization$33.11 billion
P/E Ratio49.59
Dividend Yield1.23%
Beta0.84
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, human milk oligosaccharides, and vitamins, as well as premix, market-ready solutions, and personalized nutrition; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty food enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; and Dyneema, a fiber solution for use in ropes and lines, and outdoor and sports applications. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides yeast and enzymes for the conversion of starch, corn fiber, and biomass. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Koninklijke DSM logo

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
Current SymbolOTCMKTS:RDSMY
Previous SymbolNASDAQ:RDSMY
CUSIPN/A
Phone31-45-578-2864
Employees21,313
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10.09 billion
Cash Flow$2.34 per share
Book Value$12.09 per share

Profitability

Net Income$848.96 million

Miscellaneous

Market Cap$33.11 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableNot Optionable

Headlines

Koninklijke DSM (OTCMKTS:RDSMY) Sets New 52-Week High at $46.17
April 22, 2021 |  americanbankingnews.com
Koninklijke DSM N.V. reports FY results
February 16, 2021 |  seekingalpha.com
DSM reports 2020 results
February 16, 2021 |  finance.yahoo.com
DSM reports results first nine months 2020
November 3, 2020 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

1.17 out of 5 stars

Basic Materials Sector

281st out of 851 stocks

Chemicals & Allied Products Industry

21st out of 30 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
$45.62
0.00 (0.00 %)
(As of 04/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RDSMY News and Ratings via Email

Sign-up to receive the latest news and ratings for RDSMY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Koninklijke DSM (OTCMKTS:RDSMY) Frequently Asked Questions

Is Koninklijke DSM a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Koninklijke DSM in the last twelve months. There are currently 2 sell ratings, 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Koninklijke DSM stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RDSMY, but not buy additional shares or sell existing shares.
View analyst ratings for Koninklijke DSM
or view top-rated stocks.

What stocks does MarketBeat like better than Koninklijke DSM?

Wall Street analysts have given Koninklijke DSM a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Koninklijke DSM wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Koninklijke DSM's next earnings date?

Koninklijke DSM is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Koninklijke DSM
.

How were Koninklijke DSM's earnings last quarter?

Koninklijke DSM (OTCMKTS:RDSMY) announced its quarterly earnings data on Tuesday, February, 16th. The basic materials company reported $0.29 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.21 by $0.08. The basic materials company had revenue of $2.48 billion for the quarter. Koninklijke DSM had a trailing twelve-month return on equity of 9.81% and a net margin of 6.66%.
View Koninklijke DSM's earnings history
.

How has Koninklijke DSM's stock price been impacted by COVID-19 (Coronavirus)?

Koninklijke DSM's stock was trading at $27.56 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RDSMY stock has increased by 65.5% and is now trading at $45.6199.
View which stocks have been most impacted by COVID-19
.

How often does Koninklijke DSM pay dividends? What is the dividend yield for Koninklijke DSM?

Koninklijke DSM announced a Semi-Annual dividend on Tuesday, August 4th. Shareholders of record on Friday, August 14th will be paid a dividend of $0.188 per share on Friday, September 4th. The ex-dividend date of this dividend is Thursday, August 13th.
View Koninklijke DSM's dividend history
.

Is Koninklijke DSM a good dividend stock?

Koninklijke DSM pays an annual dividend of $0.56 per share and currently has a dividend yield of 1.23%. The dividend payout ratio of Koninklijke DSM is 43.08%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Koninklijke DSM will have a dividend payout ratio of 38.10% next year. This indicates that Koninklijke DSM will be able to sustain or increase its dividend.
View Koninklijke DSM's dividend history.

Who are Koninklijke DSM's key executives?

Koninklijke DSM's management team includes the following people:
  • Mr. Dimitri de Vreeze, Co-CEO, COO & Member of the Managing Board (Age 54, Pay $1.97M)
  • Ms. Geraldine Matchett, Co-CEO, CFO & Member of the Managing Board (Age 49, Pay $1.92M)
  • Mr. Jos Op Heij, Sr. VP of Corp. Control & Accounting and Group Controller
  • Marcus Remmers, Chief Technology Officer
  • Mr. Dave Huizing, VP of Investor Relations
  • Mr. Cees Los, Director of Legal Affairs and Gen. Counsel (Age 65)
  • Ms. Lieke de Jong-Tops, Sr. Communications Mang.
  • Ms. Cristina Monteiro, Exec. VP of People & Organization
  • Mr. Rob J. Atsma, Head of Energie Beheer Nederland (Age 75)
  • Mr. Christoph G. Goppelsroeder, Pres & CEO of Nutritional Products (Age 62)

Who are some of Koninklijke DSM's key competitors?

What is Koninklijke DSM's stock symbol?

Koninklijke DSM trades on the OTCMKTS under the ticker symbol "RDSMY."

How do I buy shares of Koninklijke DSM?

Shares of RDSMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Koninklijke DSM's stock price today?

One share of RDSMY stock can currently be purchased for approximately $45.62.

How much money does Koninklijke DSM make?

Koninklijke DSM has a market capitalization of $33.11 billion and generates $10.09 billion in revenue each year. The basic materials company earns $848.96 million in net income (profit) each year or $1.30 on an earnings per share basis.

How many employees does Koninklijke DSM have?

Koninklijke DSM employs 21,313 workers across the globe.

What is Koninklijke DSM's official website?

The official website for Koninklijke DSM is www.dsm.com.

Where are Koninklijke DSM's headquarters?

Koninklijke DSM is headquartered at Het Overloon 1, Heerlrn P7, 6411 TE.

How can I contact Koninklijke DSM?

Koninklijke DSM's mailing address is Het Overloon 1, Heerlrn P7, 6411 TE. The basic materials company can be reached via phone at 31-45-578-2864.


This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.